About Cipla Biotec
Cipla Biotec is a company based in India founded in 2008 was acquired by Cipla in June 2014.. The company has 28 employees as of April 07, 2024. Cipla Biotec operates in a competitive market with competitors including Zymeworks, Xilio Therapeutics, Harbour BioMed, Ambrx and Lassen Therapeutics, among others.
- Headquarter Salcete, India
- Employees 28 as on 07 Apr, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cipla Pharma And Life Sciences Limited
- Date of Incorporation 20 Aug, 2008
- Jurisdiction Mumbai, Maharashtra, India
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cipla Biotec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cipla Biotec
Cipla Biotec has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Cipla. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
APIs, generic drugs, and formulation services are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cipla Biotec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cipla Biotec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cipla Biotec Comparisons
Competitors of Cipla Biotec
Cipla Biotec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zymeworks, Xilio Therapeutics, Harbour BioMed, Ambrx and Lassen Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Bi-specific antibodies and antibody-drug conjugates are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Tumor-selective immunotherapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Antibody therapeutics are developed for immunology and oncology diseases.
|
|
| domain | founded_year | HQ Location |
Antibody-drug conjugates are developed for cancers and metabolic disorders.
|
|
| domain | founded_year | HQ Location |
Biotherapeutics targeting cancer via interleukin-11 are developed.
|
|
| domain | founded_year | HQ Location |
Novel immuno-oncology therapeutics are acquired and developed for clinical advancement.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cipla Biotec
When was Cipla Biotec founded?
Cipla Biotec was founded in 2008.
Where is Cipla Biotec located?
Cipla Biotec is headquartered in India. It is registered at Goa, India.
How many employees does Cipla Biotec have?
As of Apr 07, 2024, the latest employee count at Cipla Biotec is 28.
What is the annual revenue of Cipla Biotec?
Annual revenue of Cipla Biotec is $2.16M as on Mar 31, 2023.
What does Cipla Biotec do?
Cipla Biotec (formerly mabpharm) develops monoclonal antibodies and peptide hormones for treatment of cancers, diabetes and Wet Age-Related Macular Degeneration. Its lead product CBT 124, a monoclonal antibody angiogenesis inhibitor which targets multiple cancers is currently under pre-clinical study. Its other products include CBT 125, a peptide hormone which got approval in India to treat diabetes; CBT 127 (mAb) for breast cancer in the development phase and CBT 128 (mAb) for Wet Age-Related Macular Degeneration in the pre-clinical study. On July 17, 2014 Ciplas unit Meditab Specialities acquired Mabpharm and since then serving as a wholly subsidiary unit of Cipla.
Who are the top competitors of Cipla Biotec?
Cipla Biotec's top competitors include Xilio Therapeutics, Ambrx and Harbour BioMed.
Who are Cipla Biotec's investors?
Cipla Biotec has 1 investor. Key investors include Cipla.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.